Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
1. Legend …………………………………………………………………………………………………………………………………………………………………………………………………… 3
2. Project ………………………………………………………………………………………………………………………………………………………………………………………………… 9
2.1 Overview …………………………………………………………………………………………………………………………………………………………………………………………… 10
2.2 Model …………………………………………………………………………………………………………………………………………………………………………………………………… 11
2.3 Materials description ………………………………………………………………………………………………………………………………………………………… 13
2.4 Milestones ……………………………………………………………………………………………………………………………………………………………………………………… 15
2.5 Partners …………………………………………………………………………………………………………………………………………………………………………………………… 16
2.6 Team ……………………………………………………………………………………………………………………………………………………………………………………………………… 17
Contacts ……………………………………………………………………………………………………………………………………………………………………………………………………… 18
waiting list for organ transplants in USA
worldwide and growing
people will be added to the list before we will finish this presentation
4
people died waiting for their organ transplants in the last 20 years.
We can`t solve this problem usingthe existing approach to transplanting organs from one person to another.
5
Global 3D Bioprinting Market is expected to reach 2566.86 million by 2024 from 409.22 million in 2016 at CAGR of 25.8%
Source: Maximize Market Research
2016 2017 2018 2019 2020 2021 2022 2023 2024
409
2566
6
Blood vessels OrgansBonesTissues
7
SOLUTION
The only way to fix this is to start creating human organs and bones on demand.
8
▪ A.D.A.M. – Advanced Development of Additive Manufacturing
▪ The Company is targeting to become the first world’s company of 3D printing of human bones and organs
▪ Registered under the laws of Delaware, head office in Groton, Connecticut, located in accelerator BioCT; R&D and manufacturing facilities - in Ukraine
▪ BioCT is long-established bioscience ecosystem, founded and supported by pool of big pharma and biotech –Pfizer, Bayer and Bristol-Myers Squibb
▪ The Company has already finished laboratory equipment installation and major part of R&D process
▪ Investments have already been raised from financial arm of Kwambio, 3D printing company headquartered in New York (www.kwambio.com) and WeFund, Early-stage Venture capital fund (www.wefund.fund)
▪ The Company will start acceleration program in BioCT(Connecticut) in 2019
10
3D scanning bones using ADAM digital platform
printing bones on demand from the cloud
cooperation with network or certified clinics
11
Ceramic bio-glass Modified biopolymer 12
Modified biopolymer
• Technology based on imitating natural bones and organs structure
• High level of strength
• High level of recoverability
Bio-glass ceramics
• Substance forms reaction with bone’s tissues
• Improve efficient ties with implant
• Stimulate osteogenesisprocesses
April 2019 June 2019
“In vitro” trials of recoverability determination, cells growth
December 2019
“In vivo” trials of implants in animals organism
May 2019
R&D of bio-glass synthesis with other substances
R&D of strength and recoverability improvement
13
Bones 3D scanningsolution
First big powdertest
Bioprinted bone structure
14
May 2019
Quality management system development start
Clinical trials start
Oct 2019 Jan 2020
Certificationof quality
management system
Aug 2020July 2020
Launch of regulatory
approval process in EU and US
Digital platform development completion
Round B
Operational milestones
Regulatory milestones
Round A
June 2019
Pre-clinical trials start
Dec 2020Aug 2018
Core part of R&D stage completion
Dec 2018
Seed round
Dec 2019
First medical usage of technologyin surgery
Sep 2019
Commercial launch of digital platform
Feb 2019
Laboratory equipment
installation
Coretechnology
commercial launch
15
Kwambio is 3D printing organic bone structure
16
Fortune 500 American manufacturer of industrial tools and household hardware
Long-established bioscience ecosystem, founded and supported by pool of big pharma and biotech
American seed accelerator
Medical device company, which provides technologies for minimally invasive and general surgery
Early-stage Venture capital fund
Volodymyr Usov
highly skilled executive with more than 9 years of experience in technology projects.
co-founder of Kwambio3D printing industry expert, author of several patents in 3D printing; founder of Gutenbergz.com (the first digital publishing house in Ukraine).
17
CEO
Denys Gurak
Chairman of the Board
3D printing industry expert; Techstarts accelerator program experience.
Dmytro Skomorokhov
VP of Business Development
USA, 93 Shennecossett Rd, Groton,CT 06340
Ukraine, 11 Vodoprovodny lane, Odessa, Ukraine,65000
18
adamproject.org